import MCQGroup from '@/components/MCQGroup'
import { Callout } from 'nextra/components'

# Bronchopneumonia: Understanding the Lobular Pneumonia Subtype

## Overview

Bronchopneumonia, also known as lobular pneumonia, is a specific form of pneumonia that involves the inflammation of the bronchi, bronchioles, and alveoli. This inflammation typically manifests as patchy consolidations, often located basally within the lung lobules. It predominantly affects children and the elderly and is commonly linked to bacterial infections. Unlike the more typical viral origins of pneumonia, bronchopneumonia is frequently associated with nosocomial, or hospital-acquired, infections.

## Hospital-Acquired Pneumonia (HAP)

Hospital-acquired pneumonia develops over 48 hours after a patient is admitted to the hospital. The primary risk factor for HAP is mechanical ventilation, although several other risk factors contribute:

- Elderly age
- Chronic pulmonary diseases
- Esophageal conditions
- Prior antibiotic use
- Paralysis or decreased consciousness

<Callout emoji="⚠️">
**Note:** It is often challenging to differentiate bronchopneumonia from other types of pneumonia due to overlapping clinical presentations.
</Callout>

## Clinical Presentation

Patients with bronchopneumonia may exhibit:

- High-grade fever
- Productive cough with purulent sputum
- Shortness of breath and tachypnea
- Chest pain or pleurisy
- Hemoptysis

A severe complication of bronchopneumonia is its potential to progress into sepsis, a life-threatening condition.

## Causative Pathogens

Bronchopneumonia may be caused by a variety of organisms, including:

**Gram-positive bacteria:**
- *Staphylococcus aureus*, including methicillin-resistant *Staphylococcus aureus* (MRSA)
- *Streptococcus pneumoniae* (less common than in community-acquired pneumonia)

**Gram-negative bacteria:**
- *Klebsiella pneumoniae*
- *Pseudomonas aeruginosa*
- *Escherichia coli*

**Fungi:**
- *Histoplasma capsulatum*, particularly harmful in immunocompromised individuals

Additionally, *ab ingestis* bronchopneumonia, resulting from aspiration, can occur.

## Diagnostic Approach

Diagnosis is clinical and supported by imaging showing new infiltrates. Suspicion is raised by:

- Fever and productive cough
- Leukocytosis or leukopenia
- Dyspnea and decreased `SpO2`
- Rales, crackles, or reduced breath sounds upon auscultation
- Low oxygen saturation on pulse oximetry

### Investigations

**Full Blood Count (FBC):**
- Leukocytosis with a high granulocyte count suggests bacterial infection.
- Elevated C-reactive protein (CRP) and procalcitonin (PCT) indicate inflammation.

**Imaging:**
- **Chest X-ray (CXR)**: Shows bilateral small patchy opacities, mainly in the lower lobes.
- **Computed Tomography (CT) Scan**: Used if CXR is inconclusive. Reveals "tree-in-bud" opacities in centrilobular regions.

**Microbiological Analysis:**
- Cultures from sputum or bronchoalveolar lavage (BAL) identify the causative pathogen.
- Serology may assist in diagnosing infections like *Histoplasma capsulatum*.

## Management

### Prescribing Practices

Outpatient treatment should align with local guidelines, often involving amoxicillin or clarithromycin.

For HAP, selection of antibiotics is guided by the risk of multidrug-resistant (MDR) pathogens and local resistance patterns:

- **Empiric Therapy:**
  - Without MDR risk factors: Use agents effective against Pseudomonas and MSSA, such as piperacillin-tazobactam, cefepime, or levofloxacin.
  - With MDR risk factors: Combine agents targeting Pseudomonas, gram-negative pathogens, and MRSA, such as piperacillin-tazobactam with an aminoglycoside or anti-pseudomonal fluoroquinolone, plus linezolid or vancomycin.

- **Specific Therapy:**
  - Tailored to microbiological findings; duration typically 7 days.
  - PCT monitoring can guide the response to antibiotic therapy.

For histoplasmosis, antifungal treatment with ketoconazole or itraconazole is standard, with amphotericin B reserved for severe cases.

### Non-Prescribing Measures

Supportive care is crucial:

- Ensure rest and adequate hydration, using IV fluids when necessary.
- Hospitalization may be indicated based on CURB-65 criteria.
- Maintain `SpO2 >94%` with oxygen therapy.

Preventive measures include smoking cessation and vaccination against influenza and pneumococcus.

## References

- [Radiopaedia: Bronchopneumonia](https://radiopaedia.org/articles/bronchopneumonia)
- Oxford Handbook of Clinical Medicine, 10th edition
- [UpToDate: Epidemiology, Pathogenesis, and Microbiology of HAP](https://www.uptodate.com/contents/epidemiology-pathogenesis-microbiology-and-diagnosis-of-hospital-acquired-and-ventilator-associated-pneumonia-in-adults?search=hospital%20acquired%20pneumonia&source=search_result&selectedTitle=2~150&usage_type=default&display_rank=2)
- [UpToDate: Treatment of HAP](https://www.uptodate.com/contents/treatment-of-hospital-acquired-and-ventilator-associated-pneumonia-in-adults?search=hospital%20acquired%20pneumonia&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1)
- [UpToDate: Risk Factors and Prevention of HAP](https://www.uptodate.com/contents/risk-factors-and-prevention-of-hospital-acquired-and-ventilator-associated-pneumonia-in-adults?search=hospital%20acquired%20pneumonia&source=search_result&selectedTitle=3~150&usage_type=default&display_rank=3)

---

<MCQGroup questions={[
  {
    question: "A 72-year-old man with a history of chronic obstructive pulmonary disease (COPD) is admitted to the hospital for an acute exacerbation. Three days into his stay, he develops a fever, productive cough with green sputum, and new-onset dyspnea. A chest X-ray reveals bilateral small patchy opacities in the lower lobes. Which of the following is the most likely diagnosis?",
    options: [
      "Community-acquired pneumonia (CAP)",
      "Hospital-acquired pneumonia (HAP)",
      "Aspiration pneumonia",
      "Pulmonary tuberculosis",
      "Acute bronchitis"
    ],
    correctAnswer: 1,
    correctFeedback: "Correct! The patient's symptoms, along with his hospitalization status and radiographic findings, are consistent with hospital-acquired pneumonia (HAP), which typically develops 48 hours or more after admission.",
    incorrectFeedback: "Consider the timing of symptom onset relative to hospital admission and the typical radiographic findings associated with each diagnosis."
  },
  {
    question: "A 65-year-old woman with bronchopneumonia shows leukocytosis with a high granulocyte count, elevated CRP, and procalcitonin levels. She reports a new productive cough and low-grade fever. Which pathogen is least likely to be the causative agent in her case?",
    options: [
      "Staphylococcus aureus",
      "Streptococcus pneumoniae",
      "Pseudomonas aeruginosa",
      "Mycobacterium tuberculosis",
      "Escherichia coli"
    ],
    correctAnswer: 3,
    correctFeedback: "Correct! While Mycobacterium tuberculosis can cause pulmonary symptoms and elevated inflammatory markers, it is not a typical causative agent of bronchopneumonia. It usually presents with chronic symptoms and a distinct radiographic pattern.",
    incorrectFeedback: "Consider the typical causative pathogens of bronchopneumonia, which often include both gram-positive and gram-negative bacteria."
  },
  {
    question: "An 80-year-old nursing home resident with a recent stroke is admitted to the hospital with bronchopneumonia. The sputum culture grows gram-negative rods. Which antibiotic regimen should be initiated empirically while awaiting further susceptibility results?",
    options: [
      "Amoxicillin-clavulanate",
      "Ceftriaxone",
      "Piperacillin-tazobactam",
      "Vancomycin",
      "Azithromycin"
    ],
    correctAnswer: 2,
    correctFeedback: "Correct! Piperacillin-tazobactam is an appropriate empiric choice for bronchopneumonia in a patient at risk for multidrug-resistant organisms, as it is effective against Pseudomonas and other gram-negative pathogens.",
    incorrectFeedback: "Consider the patient's risk factors for multidrug-resistant pathogens and choose an empiric antibiotic regimen that covers typical nosocomial bacteria, including Pseudomonas."
  },
  {
    question: "A patient diagnosed with bronchopneumonia due to Histoplasma capsulatum has a severe case with disseminated infection. Which of the following is the most appropriate initial treatment?",
    options: [
      "Ketoconazole",
      "Itraconazole",
      "Amphotericin B",
      "Vancomycin",
      "Ciprofloxacin"
    ],
    correctAnswer: 2,
    correctFeedback: "Correct! Amphotericin B is the drug of choice for severe histoplasmosis, including cases with disseminated infection.",
    incorrectFeedback: "Consider the severity of the patient's fungal infection and choose the most effective initial treatment for severe cases of histoplasmosis."
  }
]} />